{'text': 'Kean University and Sanofi Partner', 'publisher': {'href': 'https://njbmagazine.com', 'title': 'njbmagazine.com'}, 'created_at': 'Fri, 28 Aug 2015 07:00:00 GMT', 'description': 'Kean University and Sanofi Partner  njbmagazine.com', 'url': 'https://news.google.com/rss/articles/CBMifEFVX3lxTE90WERXbjMzTy1rRVRKQjFQMzJXMUtkWWNaSzd6MFU5XzA0ZUVIWENJUFRELU1vdEU3cnZpX1cySVhxVG9PTjZMdlVsSXBNRDJ3SGJRekpFdlJ4Q29lQ28yN1lSdEVfSDBQMURLYWtsNEdRY0w5RzFhd3d6S2Y?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class (Published 2015)', 'publisher': {'href': 'https://www.nytimes.com', 'title': 'The New York Times'}, 'created_at': 'Thu, 27 Aug 2015 07:00:00 GMT', 'description': 'F.D.A. Approves Repatha, a Second Drug for Cholesterol in a Potent New Class (Published 2015)  The New York Times', 'url': 'https://news.google.com/rss/articles/CBMipgFBVV95cUxPN0VHSm5nWVh5VkNwWnZuTk1QR2tpZ2ZQVS1pTnZhVWlRdGtxaVUxTWZEendjakFpUWx4UWZManNKYUNNU1h6dzE3aE1CSFZGNThTOW1aanZQNjdqN1ZFVjlkS3IxaTRTa1hDS1FreWlMRW90UGRMdFlSMEhERnA3MUxFR05YRFJqRFMxMHFycEF5S1NGdkFiQmk2NllqdnhrU2RBZUlR?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'FDA Approves New Cholesterol-Lowering Drug', 'publisher': {'href': 'https://time.com', 'title': 'TIME'}, 'created_at': 'Thu, 27 Aug 2015 07:00:00 GMT', 'description': 'FDA Approves New Cholesterol-Lowering Drug  TIME', 'url': 'https://news.google.com/rss/articles/CBMiZkFVX3lxTE1vcTJmeUEyemVXcU5DN3Z3U3RXaXZiVm5OVnhVWXB5MW5HbGtxR0JweEthXzJGUHdoQlhrVF92cnFCaWk4MThFU2tEVTlSNjZUR2p0U0J4RUlLeFVWRWNLRmNHekxMdw?oc=5&hl=en-US&gl=US&ceid=US:en'}
